Recon: US CDC postpones February vaccine advisory meeting; AstraZeneca acquires FibroGen’s China unit

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States